Skip to main content

Zynerba Pharmaceuticals, Inc.

ZYNEDelisted Oct 11, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001621443

Zynerba Pharmaceuticals, Inc. was delisted on Oct 11, 2023; its insiders filed their last Form 4 on Oct 11, 2023; 43 institutions reported holding it in 13F filings for Q3 2023, worth $14.7M in total; no superinvestor held it.

13F holders, Q2 2023

Institutional positions in Zynerba Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
41
−1 vs. Q1 2023
Shares held
5.33M
−349.1K (−6.1%) vs. Q1 2023
Total value
$1.74M
−$704.0K (−28.8%) vs. Q1 2023
New holders
4
7 more added
Sold out
5
12 more reduced

2 institutions that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ZYNE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 41 institutions
Q1 2021: 67 institutionsQ2 2021: 65 institutionsQ3 2021: 59 institutionsQ4 2021: 62 institutionsQ1 2022: 59 institutionsQ2 2022: 56 institutionsQ3 2022: 62 institutionsQ4 2022: 50 institutionsQ1 2023: 44 institutionsQ2 2023: 41 institutionsQ3 2023: 43 institutionsQ4 2023: 0 institutionsQ1 2024: 1 institutionQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2023: $1.74M
Q1 2021: $42.1MQ2 2021: $78.1MQ3 2021: $57.1MQ4 2021: $38.3MQ1 2022: $24.8MQ2 2022: $12.5MQ3 2022: $7.97MQ4 2022: $4.23MQ1 2023: $2.75MQ2 2023: $1.74MQ3 2023: $14.7MQ4 2023: $0Q1 2024: $16.2KQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ZYNE and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20241$16.2K
Q4 20230$0
Q3 202343$14.7M
Q2 202341$1.74M
Q1 202344$2.75M
Q4 202250$4.23M
Q3 202262$7.97M
Q2 202256$12.5M
Q1 202259$24.8M
Q4 202162$38.3M
Q3 202159$57.1M
Q2 202165$78.1M
Q1 202167$42.1M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Zynerba Pharmaceuticals, Inc.; share changes are against Q1 2023.

Institutions holding ZYNE in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc2,179,600$710.5K0.00%00.0%Unchanged
BlackRock Inc.740,524$241.4K0.00%−98,178−11.7%Reduced
Renaissance Technologies LLC689,713$225.0K0.00%+120,013+21.1%Added
Geode Capital Management, LLC387,346$126.3K0.00%00.0%Unchanged
Penserra Capital Management LLC220,858$71.0K0.00%+1,712+0.8%Added
Millennium Management LLC125,835$41.0K0.00%−330,514−72.4%Reduced
Two Sigma Advisers, LP124,000$40.4K0.00%−20,900−14.4%Reduced
State Street Corp119,741$39.0K0.00%00.0%Unchanged
Northern Trust Corp115,210$37.6K0.00%00.0%Unchanged
Bernardo Wealth Planning LLC78,578$25.6K0.01%+40,000+103.7%Added
Wells Fargo & Company75,907$24.7K0.00%−70,826−48.3%Reduced
Two Sigma Investments, LP70,163$22.9K0.00%−70.0%Reduced
Bridgeway Capital Management, LLC65,900$21.5K0.00%00.0%Unchanged
Sequoia Financial Advisors, LLC49,700$16.2K0.00%+49,700New
Morgan Stanley43,614$14.2K0.00%00.0%Unchanged
Charles Schwab Investment Management Inc37,596$12.3K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.37,110$12.2K0.00%−499−1.3%Reduced
Cetera Advisor Networks LLC27,454$8.95K0.00%+3,194+13.2%Added
UBS Group AG26,568$8.66K0.00%−3,718−12.3%Reduced
Bank of New York Mellon Corp26,311$8.58K0.00%−10,251−28.0%Reduced
Tower Research Capital LLC (TRC)15,817$5.16K0.00%+15,733+18,729.8%Added
King Wealth16,000$5.00K0.00%00.0%Unchanged
Raymond James Financial Services Advisors, Inc.13,900$4.53K0.00%−300−2.1%Reduced
Royal Bank of Canada12,610$4.00K0.00%+1,779+16.4%Added
JPMorgan Chase & Co9,472$3.09K0.00%+5,733+153.3%Added
Key Financial Inc7,500$2.44K0.00%00.0%Unchanged
TD Waterhouse Canada Inc.4,145$1.73K0.00%+4,145New
Newbridge Financial Services Group, Inc.4,610$1.50K0.00%−1,465−24.1%Reduced
Group One Trading, L.P.4,559$1.49K0.00%00.0%Unchanged
Founders Capital Management2,000$6520.00%00.0%Unchanged
Rhumbline Advisers805$2620.00%+805New
Sound Income Strategies, LLC350$1140.00%00.0%Unchanged
Bank of America Corp173$570.00%−27−13.5%Reduced
Harbour Investments, Inc.100$330.00%00.0%Unchanged
Kistler-Tiffany Companies, LLC100$330.00%00.0%Unchanged
HM Payson & Co50$170.00%00.0%Unchanged
FMR LLC25$80.00%−150−85.7%Reduced
GHP Investment Advisors, Inc.1$10.00%00.0%Unchanged
Lindbrook Capital, LLC1$00.00%00.0%Unchanged
Iron Horse Wealth Management, LLC1$00.00%00.0%Unchanged
IFP Advisors, Inc23––+23New
Proequities, Inc.0$00.00%−501−100.0%Sold out
Virtu Financial LLC0$00.00%−32,386−100.0%Sold out
HRT Financial LP0$00.00%−19,760−100.0%Sold out
Huntington National Bank0$00.00%−217−100.0%Sold out
Simplex Trading, LLC0$00.00%−2,274−100.0%Sold out
ETF Managers Group, LLC––––Not filed
Ahrens Investment Partners LLC––––Not filed